We are live on ! Find out more
FSTX

F-star Therapeutics, Inc. Common Stock
FSTX

Delisted

FSTX was delisted on the 8th of March, 2023.

Back to rankings

37 hedge funds and large institutions have $71.9M invested in F-star Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more call options, than puts

Call options by funds: $371K | Put options by funds: $299K

9% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 11

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less funds holding

Funds holding: 41 → 37 (-4)

23% less capital invested

Capital invested by funds: $93.5M → $71.9M (-$21.6M)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

Holders
37
Holders Change
-4
Holders Change %
-9.76%
% of All Funds
0.65%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
12
Reduced
11
Closed
8
Calls
$371K
Puts
$299K
Net Calls
+$72K
Net Calls Change
-$151K

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$686K
2
Truist Financial
Truist Financial
North Carolina
+$226K
3
State Street
State Street
Massachusetts
+$143K
4
Millennium Management
Millennium Management
New York
+$107K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$104K

Top Sellers

Rank Fund Capital Flow
1
Verition Fund Management
Verition Fund Management
Connecticut
-$1.61M
2
MIM
Monashee Investment Management
Massachusetts
-$1.58M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.29M
4
MS
Maven Securities
Jersey
-$1.26M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Boxer Capital
California
$12.8M – – –
RSCM
2
Rock Springs Capital Management
Maryland
$7.72M – – –
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$7.18M -$643K -93,751 -9%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$6.59M +$686K +100,000 +13%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$6.03M -$29.8K -4,346 -0.5%
Vanguard Group
6
Vanguard Group
Pennsylvania
$5.45M -$196K -28,592 -4%
DCM
7
DAFNA Capital Management
California
$5.08M -$141K -20,500 -3%
Janus Henderson Group
8
Janus Henderson Group
United Kingdom
$4.93M -$246K -35,894 -5%
AVA
9
Atlas Venture Advisors
Massachusetts
$4.21M – – –
BlackRock
10
BlackRock
New York
$2.12M +$4.38K +638 +0.2%
Citadel Advisors
11
Citadel Advisors
Florida
$1.9M -$1.26M -183,135 -41%
Russell Investments Group
12
Russell Investments Group
United Kingdom
$1.3M +$17.2K +2,513 +1%
MIM
13
Monashee Investment Management
Massachusetts
$1.24M -$1.58M -230,000 -58%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$1.06M +$104K +15,152 +12%
Renaissance Technologies
15
Renaissance Technologies
New York
$874K -$189K -27,600 -19%
Truist Financial
16
Truist Financial
North Carolina
$579K +$226K +33,000 +72%
TD Asset Management
17
TD Asset Management
Ontario, Canada
$428K – – –
STC
18
Sarah T. Connolly
$388K – – –
EP
19
Eversept Partners
New York
$366K -$344K -50,067 -50%
State Street
20
State Street
Massachusetts
$337K +$143K +20,900 +83%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$335K +$4.74K +690 +2%
Northern Trust
22
Northern Trust
Illinois
$257K +$4.85K +707 +2%
PCM
23
Parsons Capital Management
Rhode Island
$173K +$3.26K +475 +2%
Millennium Management
24
Millennium Management
New York
$114K +$107K +15,547 New
PCA
25
Private Capital Advisors
Connecticut
$96K – – –
1
2

FSTX Hedge Fund Activity: Q3 2021 in Review

37 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in F-star Therapeutics, Inc. Common Stock (FSTX) for Q3 2021, worth a combined $71.9M — down 23% from $93.5M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of FSTX and 4 opened new positions — a net loss of 4 holders — while 11 trimmed existing stakes and 12 added.

The largest buyer was Adage Capital Partners, adding an estimated $686K. The largest seller was Verition Fund Management, exiting entirely with an estimated $1.61M sold.

  • 37 institutional investors held F-star Therapeutics, Inc. Common Stock (FSTX) as of Q3 2021, down from 41 in Q2 2021.
  • Funds reported $71.9M of F-star Therapeutics, Inc. Common Stock stock for Q3 2021, down 23% quarter-over-quarter.
  • 4 funds opened new F-star Therapeutics, Inc. Common Stock positions in Q3 2021 and 8 closed out, a net change of -4 holders.
  • The largest F-star Therapeutics, Inc. Common Stock buyer in Q3 2021 was Adage Capital Partners, an estimated $686K added.
  • The largest F-star Therapeutics, Inc. Common Stock seller in Q3 2021 was Verition Fund Management, an estimated $1.61M sold.

Based on aggregated 13F filings for Q3 2021.